Using email (WVU\HSC\WVU Medicine) to transmit research related information?
Email and email attachments
cannot be used to transmit signed consent documents, answering questions
related to the research, personal information related to the Prospective Participant
or the Participant once consented:
- More Than Minimal Risk (MMR) Clinical Trials and Non-Clinical Trials
- Only Minimal Risk Research OMR) using PHI
- Only Minimal Risk (OMR) Research using Sensitive Data
- Only Minimal Risk (OMR) Research involving Minors (Age 18 and under)
In some cases, the IRB may permit emailing information using attachments. When
IRB approval is obtained, secure email controls must be implemented. For
example, the IRB may approved sending an unsigned Informed Consent Form as an attachment
for informational purposes to a Prospective Participant. Note signatures cannot
be obtained using email. REDCap must be used.
Sending Secure Email Messages for Research
If the WVU IRB has approved the use of email to transmit research information, the
following controls must be used to meet WVU Information Security policy. Please see the note below for sending UNSIGNED CONSENT FORMS.
- Use a nondescript Subject Line. For example, Message From WVU Research
- Include the text [SECURE] in the Subject Line. For example, [SECURE] Message From
WVU Research
The use of [SECURE] will encrypt the message and in most cases the recipient will
receive a message with a code to access the email message. All email
systems are different, therefore, the message that the recipient receives will
vary. The recipient should be alerted of the process.
-
Insert the following text into the body of the email message:
Please note that email messages are not secure, information in the subject line
and the email message could lead to unintended disclosure if received or viewed
by an unintended recipient. While protective safeguards are in place for your
information, West Virginia University cannot guarantee the security of the
information contained in email messages. We will not use email to discuss or
answer questions about the research.
NOTE: If an unsigned ICF is sent for information purposes to a Prospective Participant, the recipient should be instructed NOT to sign the document and send it back via email. Provide information of when the eICF will be sent for eSignature.